본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Interactions between vitamin B2, the MTRR rs1801394 and MTR rs1805087 genetic polymorphisms, and colorectal cancer risk in a Korean population Kim Jeong seon
(Department of Cancer AI and Digital Health)

Madhawa Gunathilake
(Department of Cancer AI and Digital Health)
. Interactions between vitamin B2, the MTRR rs1801394 and MTR rs1805087 genetic polymorphisms, and colorectal cancer risk in a Korean population. EPIDEMIOLOGY AND HEALTH. 2024-03-11; 2024; 46:e2024037~. IF 2.2 (2023)
Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study Choi Yoon Jin
(Branch of Gastroenterology)


()
. Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study. MATURITAS. 2024-03-09; 2024; 184:107960~. IF 3.9 (2023)
Extracellular Vesicles from Cerebrospinal Fluid of Leptomeningeal Metastasis Patients Deliver MiR-21 and Induce Methotrexate Resistance in Lung Cancer Cells Kim Jong Heon
(Cancer Molecular Biology Branch)


()
. Extracellular Vesicles from Cerebrospinal Fluid of Leptomeningeal Metastasis Patients Deliver MiR-21 and Induce Methotrexate Resistance in Lung Cancer Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024-03-08; 2024; 25(6):3124~. IF 4.9 (2023)
Obesity and mortality in patients with COVID-19: A meta-analysis of prospective studies Myung, Seung-Kwon
(Department of Cancer AI and Digital Health)


()
. Obesity and mortality in patients with COVID-19: A meta-analysis of prospective studies. ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION. 2024-03-01; 2024; 33(1):56~65. IF 1.3 (2023)
The efficacy of slow-rate ventriculolumbar perfusion chemotherapy for leptomeningeal carcinomatosis: a phase II study Gwak Ho Shin
(Department of Cancer Control and Population Health)


()
. The efficacy of slow-rate ventriculolumbar perfusion chemotherapy for leptomeningeal carcinomatosis: a phase II study. ACTA NEUROCHIRURGICA. 2024-03-01; 2024; 166(1):117~. IF 1.9 (2023)
Differential response to roflumilast in patients with chronic obstructive pulmonary disease: real-world evidence
()

Sun Ji Yu
(Integrated Biostatistics Branch)
. Differential response to roflumilast in patients with chronic obstructive pulmonary disease: real-world evidence. Journal of Thoracic Disease. 2024-02-27; 2024; 16(2):1338~1349. IF 2.1 (2023)
Cancer risk according to fasting blood glucose trajectories: A population-based cohort study Oh J K
(Department of Clinical Nursing Science)

Thu Thi Minh KHONG
(Department of Cancer Biomedical Science)
. Cancer risk according to fasting blood glucose trajectories: A population-based cohort study. BMJ Open Diabetes Research & Care. 2024-02-27; 2024; 12(1):e003696~. IF 3.7 (2023)
Factors related to tumor response rate from TCGA three omics data-variants, expression, methylation
()

Ahn Hyung-Min
(Center for Lung Cancer)
. Factors related to tumor response rate from TCGA three omics data-variants, expression, methylation. Journal of Environmental Science and Health Part C-Toxicology and Carcinogenesis. 2024-02-26; 2024; 42(3):173~188. IF 1.2 (2023)
Correspondence on Editorial regarding Lee Yeon Su
(Rare & Pediatric Cancer Branch)


()
. Correspondence on Editorial regarding "Identification of signature gene set as highly accurate determination of MASLD progression". Clinical and Molecular Hepatology. 2024-02-23; 2024; 30(2):287~290. IF 14 (2023)
The interaction between magnesium intake, the genetic variant INSR rs1799817 and colorectal cancer risk in a Korean population: a case-control study Kim Jeong seon
(Department of Cancer AI and Digital Health)


(Department of Cancer Biomedical Science)
. The interaction between magnesium intake, the genetic variant INSR rs1799817 and colorectal cancer risk in a Korean population: a case-control study. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION. 2024-02-22; 2024; 75(4):396~406. IF 3.5 (2023)